Ramez Kouzy

1.6k total citations · 1 hit paper
51 papers, 839 citations indexed

About

Ramez Kouzy is a scholar working on Economics and Econometrics, Statistics and Probability and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ramez Kouzy has authored 51 papers receiving a total of 839 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Economics and Econometrics, 17 papers in Statistics and Probability and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ramez Kouzy's work include Health Systems, Economic Evaluations, Quality of Life (19 papers), Statistical Methods in Clinical Trials (17 papers) and Pancreatic and Hepatic Oncology Research (8 papers). Ramez Kouzy is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (19 papers), Statistical Methods in Clinical Trials (17 papers) and Pancreatic and Hepatic Oncology Research (8 papers). Ramez Kouzy collaborates with scholars based in United States, Israel and Canada. Ramez Kouzy's co-authors include Joseph Abi Jaoude, Molly B. El Alam, Basil S. Karam, Elio Adib, Elie A. Akl, Khalil Baddour, Cindy Traboulsi, Jabra Zarka, Afif Kraitem and Cullen M. Taniguchi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Ramez Kouzy

42 papers receiving 800 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Coronavirus Goes Viral: Quantifying the COVID-19 Misinformation Epidemic on Twitter

2020 586 citations Ramez Kouzy, Joseph Abi Jaoude et al. Cureus profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ramez Kouzy United States	10	460	178	156	141	92	51	839
Joseph Abi Jaoude United States	12	461 1.0×	201 1.1×	156 1.0×	141 1.0×	165 1.8×	65	1.0k
Molly B. El Alam United States	7	461 1.0×	177 1.0×	156 1.0×	141 1.0×	78 0.8×	14	669
Khalil Baddour United States	8	467 1.0×	176 1.0×	152 1.0×	141 1.0×	74 0.8×	14	750
Elio Adib United States	10	459 1.0×	174 1.0×	153 1.0×	141 1.0×	71 0.8×	41	924
Cindy Traboulsi United States	10	459 1.0×	175 1.0×	152 1.0×	141 1.0×	162 1.8×	28	771
Mohammad Ariful Islam Bangladesh	6	448 1.0×	201 1.1×	126 0.8×	98 0.7×	54 0.6×	17	714
Jabra Zarka United States	6	459 1.0×	174 1.0×	152 1.0×	141 1.0×	53 0.6×	8	682
Jodyn Platt United States	18	214 0.5×	117 0.7×	67 0.4×	25 0.2×	46 0.5×	64	1.1k
S Sommariva United States	11	198 0.4×	106 0.6×	33 0.2×	74 0.5×	89 1.0×	28	667
Abu-Hena Mostofa Kamal Australia	6	646 1.4×	458 2.6×	167 1.1×	125 0.9×	66 0.7×	7	1.1k

Countries citing papers authored by Ramez Kouzy

Since Specialization

Citations

This map shows the geographic impact of Ramez Kouzy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramez Kouzy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramez Kouzy more than expected).

Fields of papers citing papers by Ramez Kouzy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ramez Kouzy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramez Kouzy. The network helps show where Ramez Kouzy may publish in the future.

Co-authorship network of co-authors of Ramez Kouzy

This figure shows the co-authorship network connecting the top 25 collaborators of Ramez Kouzy. A scholar is included among the top collaborators of Ramez Kouzy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramez Kouzy. Ramez Kouzy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kouzy, Ramez, Lauren E. Colbert, Miao Zhang, et al.. (2025). Urethral Adenocarcinoma: A Rare Malignancy With Poor Oncologic Outcomes Despite Neoadjuvant Treatment and Consolidative Therapy. JU Open Plus. 3(3).

Kouzy, Ramez, et al.. (2025). Review of Large Language Models for Patient and Caregiver Support in Cancer Care Delivery. JCO Clinical Cancer Informatics. 9(9). e2500044–e2500044.

Kouzy, Ramez, Michael K. Rooney, Jean Feng, et al.. (2025). The state of the art in artificial intelligence and digital pathology in prostate cancer. Nature Reviews Urology. 23(1). 13–28. 1 indexed citations

Grippin, Adam, Erin L. Young, Ellen T. Chang, et al.. (2024). 995MO Association of SARS-COV-2 mRNA vaccines with tumor PD-L1 expression and clinical responses to immune checkpoint blockade. Annals of Oncology. 35. S677–S678. 2 indexed citations

Sherry, Alexander D., Zachary R. McCaw, Joseph Abi Jaoude, et al.. (2024). Increasing Power in Phase III Oncology Trials With Multivariable Regression: An Empirical Assessment of 535 Primary End Point Analyses. JCO Clinical Cancer Informatics. 8(8). e2400102–e2400102. 4 indexed citations

Sherry, Alexander D., Marcus A. Florez, Ramez Kouzy, et al.. (2024). Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials. Cancer Research Communications. 4(8). 2183–2188. 1 indexed citations

Lin, Timothy A., Zachary R. McCaw, Joseph Abi Jaoude, et al.. (2024). Proportional Hazards Violations in Phase III Cancer Clinical Trials: A Potential Source of Trial Misinterpretation. Clinical Cancer Research. 30(20). 4791–4799. 4 indexed citations

Nalin, Ansel P., Adam Grippin, Ramez Kouzy, et al.. (2024). Prevalence of Control Arm Overperformance as a Contributing Factor to Optimism Bias in Phase 3 Oncology Clinical Trials. International Journal of Radiation Oncology*Biology*Physics. 120(2). S129–S129. 1 indexed citations

Liu, Ying, Timothy A. Lin, Christine Lin, et al.. (2024). The Fragility of Phase III Trials in Oncology. International Journal of Radiation Oncology*Biology*Physics. 120(2). S42–S42.

10.

Sherry, Alexander D., Andrew W. Hahn, Zachary R. McCaw, et al.. (2024). Differential Treatment Effects of Subgroup Analyses in Phase 3 Oncology Trials From 2004 to 2020. JAMA Network Open. 7(3). e243379–e243379. 3 indexed citations

11.

Sherry, Alexander D., Timothy A. Lin, Zachary R. McCaw, et al.. (2024). Off-Protocol Radiation Therapy in Phase 3 Metastatic Solid Tumor Trials. International Journal of Radiation Oncology*Biology*Physics. 120(5). 1239–1244.

12.

Corrigan, Kelsey L., Bryce B. Reeve, John M. Salsman, et al.. (2023). Health-related quality of life in adolescents and young adults with cancer who received radiation therapy: a scoping review. Supportive Care in Cancer. 31(4). 230–230. 3 indexed citations

13.

Corrigan, Kelsey L., et al.. (2023). Selection and Prejudice: Addressing Clinical Trial Disparities With a Review of Current Shortcomings and Future Directions. Seminars in Radiation Oncology. 33(4). 367–373. 2 indexed citations

14.

Sherry, Alexander D., Kelsey L. Corrigan, Ramez Kouzy, et al.. (2023). Prevalence, trends, and characteristics of trials investigating local therapy in contemporary phase 3 clinical cancer research. Cancer. 129(21). 3430–3438. 9 indexed citations

15.

Florez, Marcus A., Joseph Abi Jaoude, Roshal R. Patel, et al.. (2023). Incidence of Primary End Point Changes Among Active Cancer Phase 3 Randomized Clinical Trials. JAMA Network Open. 6(5). e2313819–e2313819. 7 indexed citations

16.

Sherry, Alexander D., Pavlos Msaouel, Zachary R. McCaw, et al.. (2023). Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy. European Journal of Cancer. 194. 113357–113357. 6 indexed citations

17.

Kouzy, Ramez, et al.. (2020). Applying to Radiation Oncology Amid a Pandemic. Advances in Radiation Oncology. 5(4). 777–779. 1 indexed citations

18.

Lin, Daniel, Ramez Kouzy, Joseph Abi Jaoude, et al.. (2020). Microbiome factors in HPV-driven carcinogenesis and cancers. PLoS Pathogens. 16(6). e1008524–e1008524. 48 indexed citations

19.

Jaoude, Joseph Abi, Ramez Kouzy, Nicholas D. Nguyen, et al.. (2020). Radiation therapy for patients with locally advanced pancreatic cancer: Evolving techniques and treatment strategies. Current Problems in Cancer. 44(6). 100607–100607. 16 indexed citations

20.

Kouzy, Ramez, et al.. (2018). A Case of Typical Hemolytic Uremic Syndrome in an Adult. Cureus. 10(9). e3289–e3289. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact